Kymera Therapeutics, Inc. (KYMR)
NASDAQ: KYMR · Real-Time Price · USD
83.85
-2.83 (-3.26%)
At close: Apr 28, 2026, 4:00 PM EDT
83.85
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:10 PM EDT
Kymera Therapeutics Employees
Kymera Therapeutics had 238 employees as of December 31, 2025. The number of employees increased by 50 or 26.60% compared to the previous year.
Employees
238
Change (1Y)
50
Growth (1Y)
26.60%
Revenue / Employee
$164,752
Profits / Employee
-$1,308,197
Market Cap
6.85B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| ImmunityBio | 691 |
| Halozyme Therapeutics | 423 |
| Krystal Biotech | 295 |
| Apogee Therapeutics | 261 |
| Arcellx | 209 |
| Protagonist Therapeutics | 132 |
| Centessa Pharmaceuticals | 118 |
| Erasca | 103 |
KYMR News
- 5 days ago - Kymera Therapeutics to Report First Quarter 2026 Financial Results on April 30, 2026 - GlobeNewsWire
- 15 days ago - Kymera Therapeutics Announces U.S. FDA Fast Track Designation for KT-621, a First-in-Class, Oral STAT6 Degrader for the Treatment of Moderate to Severe Asthma - GlobeNewsWire
- 4 weeks ago - Kymera Therapeutics Presents KT-621 BroADen Data in Late-Breaking Research Session at the American Academy of Dermatology (AAD) Annual Meeting - GlobeNewsWire
- 6 weeks ago - Kymera Therapeutics Transcript: Barclays 28th Annual Global Healthcare Conference - Transcripts
- 7 weeks ago - Kymera Therapeutics Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 7 weeks ago - Kymera Therapeutics Announces Late-Breaking Oral Presentation of KT-621 Phase 1b Data at the American Academy of Dermatology (AAD) Annual Meeting - GlobeNewsWire
- 2 months ago - Kymera Therapeutics Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - Kymera Therapeutics Transcript: Oppenheimer 36th Annual Healthcare Life Sciences Conference - Transcripts